Dear PES Members, As a dual US and Canadian citizen, I admit that I find these times particularly sad and…
Read MoreMore Articles
Professor Pierre Sizonenko died 13 February, 2023 at his home in Geneva, Switzerland, after a 15-year battle with multiple myeloma. Pierre was born and educated in Paris, followed by a…
Read More
The use of glucagon-like-peptide-1 (GLP-1) receptor agonists for the treatment of obesity has increased significantly over the past year. Due to high demands and limited supply, patients and clinicians are…
Read More
Augustine Joseph “Joe” D’Ercole, M.D., one of the giants of pediatric endocrinology, died on December 21, 2023 at home in Chapel Hill, NC. Joe graduated from the University of…
Read More
Holiday greetings to all PES Members and Friends! As we close out another calendar year, one naturally considers 2023’s issues and events. The year will be most remembered for our…
Read More
Fulfilled Ighalo, MD I am currently in my second year of pediatric endocrinology fellowship at Baylor College of Medicine/Texas Children’s Hospital in Houston, Texas. I obtained my medical degree at…
Read More
Friedrich Wöhler (July 31, 1800 to September 3, 1882) and the Synthesis of Urea Submitted by Alan Rogol, MD Friedrich Wöhler was a German chemist who worked in both the…
Read More
Dr. Barry B. Bercu 1944-2023 Barry B. Bercu, M.D. died on Friday, November 24, 2023. Dr. Bercu, a pediatric endocrinologist long associated with the University of South Florida, was internationally…
Read More
Dear PES members and friends, With the advancing fall, our recent elections led to an outstanding slate of new leaders for next year. Congratulations to Laurie Cohen, Andrew Dauber, and…
Read More
Medication Shortage Alert – Pamidronate Disodium Injection: Anna Ryabets-Lienhard, DO, Drugs and Therapeutics Committee Update 10/25/23: As of August-September, there has been a national shortage of pamidronate IV injection. The…
Read More
Novo Nordisk announced on 11/8/2023 that their long-acting insulin, Levemir®, will be phased out from United States markers completely discontinuing by December 2024. It cited manufacturing constraints, reduced patient access and…
Read More